Merrill A. Mcpeak - 20 Feb 2024 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Reporting relationship: Director
Issuer ticker: IOVA
Reported as of: 20 Feb 2024
Net transaction value: +$2,287,500
SEC form: 4
Accepted by SEC: 20 Feb 2024, 19:52:18 UTC
Prior SEC filing: 08 Dec 2023
Next SEC filing: 05 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Merrill A. McPeak

Key filing fact

Merrill A. Mcpeak filed Form 4 for IOVANCE BIOTHERAPEUTICS, INC. (IOVA) on 20 Feb 2024.

Key facts

This page summarizes Merrill A. Mcpeak's Form 4 filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Feb 2024, 19:52.

Change

Previous filing in this sequence was filed on 08 Dec 2023.
Current net transaction value: +$2,287,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IOVA transaction

Common Stock

Purchase

Transaction value: $2,287,500
Shares: +250,000
Change %: +356%
Price: $9.15
Shares after: 320,150
Date: 20 Feb 2024
Ownership: Direct
Footnotes: F2, F4

IOVA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 248,633
Date: 20 Feb 2024
Ownership: By Trust
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

These shares are held by a family trust for which the reporting person is a trustee.

Footnote F2

Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024.

Footnote F3

Such number does not include 103,159 deferred restricted stock units, which are vested but not yet issued.

Footnote F4

Consists of 30,150 shares held in Keogh retirement account plus 40,000 shares as a result of exercised stock options plus 250,000 shares acquired in this offering.